Real-time enrollment status for this moderately to severely active crohns disease clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 9:55 AM UTC
| NCT Number | NCT07298421 |
| Recruiting Status | Recruiting |
| Condition | Moderately to Severely Active Crohns Disease |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | August 10, 2026 (3 weeks ago) |
As of September 1, 2026: Clinical trial NCT07298421 is currently recruiting participants. This phase3 study for moderately to severely active crohns disease is actively seeking new participants at 1 location across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07298421 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07298421 was last updated 3 weeks ago (August 10, 2026). HelloStudys verifies this status automatically.